{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:12:36Z","timestamp":1793301156149,"version":"4.5.0"},"reference-count":43,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Clozapine is a gold-standard antipsychotic for treatment-resistant schizophrenia, increasingly used off-label for severe autism spectrum disorder (ASD) with irritability or disruptive behaviors. This study evaluated clozapine\u2019s efficacy and tolerability in children and adolescents with ASD or schizophrenia spectrum disorders (SSDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A retrospective review of 26 inpatients (ASD:\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u20098; SSD:\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200918) treated with clozapine included demographics, dosing, and hospitalization data. Symptom severity was assessed with the Clinical Global Impression-Severity Scale (CGI-S), Scale for the Assessment of Negative Symptoms (SANSs), Scale for the Assessment of Positive Symptoms (SAPSs), and Aberrant Behavior Checklist (ABC). Side effects were evaluated with the Ugvalg for Kliniske Unders\u00f8gelser (UKU) Side Effect Rating Scale. Hematological parameters\u2014white blood cells, neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio (NLR)\u2014were compared pre-treatment and at 6\u2009months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 26 patients, 50% had early-onset schizophrenia, 30.8% had ASD, and 19.2% had schizoaffective disorder. Clozapine was initiated at a mean age of 15.8\u2009years, with a mean dose of 284.6\u2009mg\/day. Both SSD (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and ASD (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.01) groups showed significant CGI improvement. SANS and SAPS improved in SSD (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.001,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001); ABC improved in ASD (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.012). UKU scores decreased in SSD (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and trended downward in ASD (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.38). Hypersalivation (61.5%), increased appetite (53.8%), and sedation (34.6%) were common; no discontinuations occurred. Neutrophils increased (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.007), and lymphocytes decreased (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.037), with significant NLR elevation in SSD (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.006).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Clozapine demonstrated strong efficacy and improved tolerability, reducing side effects compared to prior polypharmacy in refractory pediatric ASD and SSD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811251414347","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:22:16Z","timestamp":1771233736000},"page":"554-562","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Clozapine treatment in adolescents with schizophrenia and autism spectrum disorder: Comparative clinical profiles and treatment outcomes from a retrospective study"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5937-0749","authenticated-orcid":false,"given":"Melike","family":"Uysal","sequence":"first","affiliation":[{"name":"Child and Adolescent Psychiatry Clinic, K\u0131r\u0131kkale High Specialization Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6058-7857","authenticated-orcid":false,"given":"Dilan","family":"Aydin Ayva","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University Yenimahalle Research and Training Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Fatih","family":"Ceylan","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University Yenimahalle Research and Training Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4816-0228","authenticated-orcid":false,"given":"Selma","family":"Tural Hesapcioglu","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Ankara Y\u0131ld\u0131r\u0131m Beyaz\u0131t University Yenimahalle Research and Training Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2021.0092"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-012-1656-z"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2023.0097"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000871"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2024.02.005"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241241384"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010232"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-024-02623-3"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2019.08.017"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03327-7"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-023-06431-6"},{"issue":"10","key":"e_1_3_2_13_1","first-page":"429","article-title":"Clozapine-induced transient white blood count disorders","volume":"55","author":"Hummer M","year":"1994","unstructured":"Hummer M, Kurz M, Barnas C, et al. (1994) Clozapine-induced transient white blood count disorders. The Journal of Clinical Psychiatry 55(10): 429\u2013432.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/eip.13174"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2018.12.017"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0103"},{"issue":"3","key":"e_1_3_2_17_1","article-title":"Antipsychotic medication for childhood-onset schizophrenia","volume":"2007","author":"Kennedy E","year":"2007","unstructured":"Kennedy E, Kumar A, Datta SS (2007) Antipsychotic medication for childhood-onset schizophrenia. Cochrane Database of Systematic Reviews 2007(3): CD004027.","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"e_1_3_2_18_1","first-page":"36","article-title":"Retrospective review of clozapine use in children and adolescents","volume":"30","author":"Komaryk A","year":"2021","unstructured":"Komaryk A, Elbe D, Burgess L (2021) Retrospective review of clozapine use in children and adolescents. Journal of the Canadian Academy of Child and Adolescent Psychiatry 30(1): 36.","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-021-01898-0"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30289-5"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2887"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2011.01.032"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2017.03.013"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1362361320975311"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2022.12.011"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.907123"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.856208"},{"key":"e_1_3_2_28_1","author":"The National Institute for Health and Care Excellence (NICE)","year":"2014","unstructured":"The National Institute for Health and Care Excellence (NICE) (2014) Psychosis and schizophrenia in adults: Treatment and management. Reportno. Report Number|, Date. Place Published|: Institution|.","journal-title":"Psychosis and schizophrenia in adults: Treatment and management"},{"issue":"2","key":"e_1_3_2_29_1","first-page":"101","article-title":"Ergen Pop\u00fclasyonunda Klozapine Ba\u011fl\u0131 Yan Etkiler ve Bunlar\u0131n Y\u00f6netimi: Yatakl\u0131 Bir Klinikte Naturalistik G\u00f6zlem \u00c7al\u0131\u015fmas\u0131","volume":"32","author":"Ocako\u011flu BK","year":"2025","unstructured":"Ocako\u011flu BK (2025) Ergen Pop\u00fclasyonunda Klozapine Ba\u011fl\u0131 Yan Etkiler ve Bunlar\u0131n Y\u00f6netimi: Yatakl\u0131 Bir Klinikte Naturalistik G\u00f6zlem \u00c7al\u0131\u015fmas\u0131. Turkish Journal of Child and Adolescent Mental Health 32(2): 101\u2013109.","journal-title":"Turkish Journal of Child and Adolescent Mental Health"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080816"},{"key":"e_1_3_2_31_1","volume-title":"Kaplan and Sadock\u2019s Concise Textbook of Child and Adolescent Psychiatry","author":"Sadock BJ","year":"2009","unstructured":"Sadock BJ, Sadock VA, Kaplan HI (2009) Kaplan and Sadock\u2019s Concise Textbook of Child and Adolescent Psychiatry. Lippincott Williams & Wilkins."},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2017.07.012"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.117720"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2015.02.003"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2021.61"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719002083"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01161-7"},{"key":"e_1_3_2_38_1","volume-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor DM","year":"2025","unstructured":"Taylor DM, Barnes TR, Young AH (2025) The Maudsley Prescribing Guidelines in Psychiatry. John Wiley & Sons."},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316683151"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01613-2"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0216"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-2484-x"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0020"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.06.011"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251414347","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811251414347","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251414347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T21:19:46Z","timestamp":1782076786000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811251414347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1177\/02698811251414347"],"URL":"https:\/\/doi.org\/10.1177\/02698811251414347","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]}}}